Clarithromycin Tablet, Film Coated, Extended Release
Product Images NDC 0591-2805

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 0591-2805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

2 (Image 2)

2 (Image 2)
FDA Label Image

3 (Image 3)

3 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
FDA Label Image

1 (Image 5)

1 (Image 5)
NDC 0591-2805-60 is a medication with 500mg of Clarithromycin, USP per film-coated tablet. It should be dispensed in a USP tight container, and the usual dosage is two tablets once daily. The text mentions extended-release tablets, but it is not clear if these are the same as the film-coated tablets. The product is distributed by Actavis in the USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.